Hydroxyurea for the Treatment of Sickle Cell Disease docx

Hydroxyurea for the Treatment of Sickle Cell Disease docx

Ngày tải lên : 05/03/2014, 10:20
... hydroxyurea for sickle cell disease. The dosing of hydroxyurea for sickle cell disease is comparable to that in other diseases, although in the case of malignant disease, more drug is often ... hydroxyurea treatment for patients who have sickle cell disease? 2. What is the effectiveness (in everyday practice) of hydroxyurea treatment for patients who have sickle cell disease? 3. ... adults with sickle cell disease; the evidence in other diseases was only low- grade. Barriers to the Use of Hydroxyurea and Other Treatments for Managing Sickle Cell Disease Only two studies...
298 1.1K 0
Báo cáo khoa học: The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer’s disease pptx

Báo cáo khoa học: The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer’s disease pptx

Ngày tải lên : 07/03/2014, 10:20
... as a therapeutic strategy for the treatment of Alzheimer’s disease Peter J. Crouch 1 , Anthony R. White 1 and Ashley I. Bush 2,3 1 Department of Pathology and Centre for Neuroscience, The University ... dysfunctional events characteristic of Alzheimer’s disease. Metal-based therapeutics have already provided promising results for the treatment of Alzheimer’s disease, and new generations of pharmaceuticals ... [75], may therefore repre- sent a potential therapeutic strategy for preventing the tau hyperphosphorylation and NFT formation characteristic of AD. Modulation of metal availability for treating...
9 634 0
KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) pdf

KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) pdf

Ngày tải lên : 22/03/2014, 09:20
... considered in patients before treatment with bisphosphonates, because bone biopsy is the most accurate test for the diagnosis of adynamic bone disease, and the presence of adynamic bone disease is a contraindication ... than treatment targets. For the question related to parathyroidectomy vs medical management for secondary or tertiary hyperparathyroidism, a search was run for ‘parathyroidectomy’ and ‘kidney disease published ... especially in areas in which RCTs are feasible. EXCLUSION/INCLUSION CRITERIA FOR ARTICLE SELECTION FOR NONTREATMENT QUESTIONS For studies related to questions of diagnosis, prevalence, and natural...
140 777 1
Báo cáo khoa học: "Medical treatment for the terminally ill: the ‘risk of unacceptable badness’"

Báo cáo khoa học: "Medical treatment for the terminally ill: the ‘risk of unacceptable badness’"

Ngày tải lên : 25/10/2012, 10:45
... pain, suffering, and discomfort. The fundamental maxim for these patients should be comfort. Extraordinary life support for patients predicted to die does not equal comfort care. Competing interests The ... uncommon for physicians to ask loaded questions in their quest for end-of-life decisions. For example, ‘This is your grandmother’s 17th transfer from a skilled nursing facility in 3 months for sepsis ... discussions, we must strive for ‘consensus without consent’ [15]. Discussions with surrogates should strive for concordance and understanding but not extend to soliciting their consent for medically inappropriate...
2 463 0
Báo cáo y học: "Percutaneous laser disc decompression for thoracic disc disease: report of 10 cases"

Báo cáo y học: "Percutaneous laser disc decompression for thoracic disc disease: report of 10 cases"

Ngày tải lên : 26/10/2012, 09:07
... PLDD for the treatment of thoracic disc disease, we performed a study of ten patients with thoracic discogenic pain who were unresponsive to conservative intervention. Methods We performed ... with a lumbar location for the major- ity of intervertebral disc herniations, most published studies have focused on the use of PLDD for the treatment of lumbar disc disease. Thoracic discogenic ... minimally invasive treatment option for vertebral disc herniation refractory to conservative treatment. PLDD was first used in 1986 and received approval from the U.S. Food and Drug Administration...
5 593 0
Advances in StentTherapy for Ischaemic Heart Disease

Advances in StentTherapy for Ischaemic Heart Disease

Ngày tải lên : 26/01/2013, 11:02
... of 1.2 mm associated with a 50% chance of binary restenosis Probability for Restenosis Probability for Probability for Restenosis Restenosis Popma J . TAXUS IV Angiographic Results 2003. ... >0.6mm increasing probability of TLR Probability for TLR Probability for TLR Popma J . TAXUS IV Angiographic Results 2003. Late loss of 1.6 mm associated with a 50% chance for TLR Mak Heart Late Loss in TAXUS ... index procedure Percentage P<0.0001 92.2% 92.2% 81.6% 81.6% Advances in Stent Therapy for Ischaemic Heart Disease Koon-Hou Mak MD, FRCP, FACC Consultant Cardiologist Gleneagles Medical Centre Singapore ...
38 375 0
Tài liệu Báo cáo khoa học: Helicases ) feasible antimalarial drug target for Plasmodium falciparum pptx

Tài liệu Báo cáo khoa học: Helicases ) feasible antimalarial drug target for Plasmodium falciparum pptx

Ngày tải lên : 18/02/2014, 16:20
... responsible for the most severe form of the disease and this par- asite is developing resistance to the major antimalarial drugs. Therefore, in order to control malaria it is necessary to identify new drug ... prefers a fork-like substrate for its unwinding activity [18]. Helicases as drug and therapeutic target Resistance to the most efficient, reasonably priced and safe antimalarials has called for the ... cel- lular RNA helicases as antiviral targets. Nat Rev Drug Discov 4, 845–853. 27 Frick DN (2003) Helicases as antiviral drug targets. Drug News Persp 16, 355–362. 28 Frick DN & Lam AM (2006)...
6 496 0

Xem thêm